ASCO starts enrolling TAPUR trial

The American Society of Clinical Oncology started enrolling patients in its Targeted Agent and Profiling Utilization Registry (TAPUR) study, a so-called basket trial that will evaluate the off-label uses of marketed, targeted therapies in a real-world setting.

TAPUR is enrolling patients with advanced solid tumors, B cell non-Hodgkin's lymphoma or multiple myeloma for whom there are no standard treatment options. Physicians will choose the appropriate therapy based on genomic screening for relevant mutations performed by any CLIA-certified laboratory. ...